Dystrobrevin, beta (DTNB) (C-Term) Peptide
DTNB
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Dystrobrevin beta (DTNB) products
- Dystrobrevin beta (DTNB) (Dystrobrevin, beta (DTNB))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- STPTHCPQDS LSGVGGDVQE AFAQGTRRNL RNDLLVAADS ITNTMSSLVK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DTNB Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Dystrobrevin beta (DTNB) (Dystrobrevin, beta (DTNB))
- Background
-
This gene encodes dystrobrevin beta, a component of the dystrophin-associated protein complex (DPC). The DPC consists of dystrophin and several integral and peripheral membrane proteins, including dystroglycans, sarcoglycans, syntrophins and dystrobrevin alpha and beta. The DPC localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. Dystrobrevin beta is thought to interact with syntrophin and the DP71 short form of dystrophin. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: DTNB,
Protein Size: 545 - Gene ID
- 1838
-
You are here:
